Invesco

Invesco’s Repare Therapeutics RPTX Stock Holding History

Invesco’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,315	Closed	-$102K	–	3932
2023 Q1	$102K	Buy	+10,315	New	+$118K	﹤0.01%	3703

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Invesco's RPTX Position: Q2 2023 in Review

Invesco sold out of Repare Therapeutics (RPTX) in Q2 2023, closing a stake of 10,315 shares — an estimated $102K sold.

Invesco first reported a position in RPTX in Q1 2023 and held it in 1 quarter. The position peaked at $102K in Q1 2023. 78 funds tracked by Wall St. Rank hold RPTX as of Q2 2023.

Invesco reported no remaining Repare Therapeutics position as of Q2 2023 after selling out during the quarter.
Invesco sold 10,315 Repare Therapeutics shares in Q2 2023, an estimated $102K.
Invesco first reported a position in Repare Therapeutics in Q1 2023 and held it in 1 quarter.
Invesco's Repare Therapeutics position peaked at $102K in Q1 2023.
78 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2023.

Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.